Long-term follow-up of recovered MPN patients with COVID-19

Simple item page
dc.contributor.authorBarbui, Tiziano
dc.contributor.authorAndrade-Campos, Marcio
dc.contributor.authorBellosillo Paricio, Beatriz
dc.contributor.authorRambaldi, Alessandro
dc.date.accessioned2022-07-19T06:36:30Z
dc.date.available2022-07-19T06:36:30Z
dc.date.issued2021
dc.description.sponsorshipThe study was supported by a research grant by the COVID “3×1 project”, BREMBO S.p.A., Bergamo, Italy (TB) and by AIRC 5×1000 call “Metastatic disease: the key unmet need in oncology” to MYNERVA project, #21267 (MYeloid NEoplasms Research Venture AIRC). A detailed description of the MYNERVA project is available at https://progettomynerva.it (AMV, PG). The study was also supported by HARMONY PLUS, which is funded through the Innovative Medicines Initiative (IMI), Europe’s largest public-private initiative aiming to speed up the development of better and safer medicines for patients. The HARMONY Alliance has received funding from IMI 2 Joint Undertaking and is listed under grant agreement No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
dc.format.mimetypeapplication/pdf
dc.identifier.citationBarbui T, Iurlo A, Masciulli A, Carobbio A, Ghirardi A, Rossi G, et al. Long-term follow-up of recovered MPN patients with COVID-19.Blood Cancer J. 2021 Jun 16; 11(6): 115. DOI: 10.1038/s41408-021-00509-0
dc.identifier.doihttp://dx.doi.org/10.1038/s41408-021-00509-0
dc.identifier.issn2044-5385
dc.identifier.urihttp://hdl.handle.net/10230/53758
dc.language.isoeng
dc.publisherNature Research
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/945406
dc.rightsThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.keywordCOVID-19 - complications
dc.subject.keywordCOVID-19 - mortality
dc.subject.keywordLeukemia
dc.subject.keywordMyeloid
dc.subject.keywordLymphoma, non-Hodgkin
dc.subject.keywordMyeloproliferative disorders
dc.titleLong-term follow-up of recovered MPN patients with COVID-19
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/publishedVersion

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
barbui-blc-long.pdf
Size:
973 KB
Format:
Adobe Portable Document Format
Download

Collections

License

Rights